Waters Corporation (WAT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Waters Corporation (WAT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y
WAT tops Q4 estimates as revenues rise 7% Y/Y, with strong Pharma and Europe growth, and upbeat 2026 sales and earnings outlook.
Down 19.0% in 4 Weeks, Here's Why Waters (WAT) Looks Ripe for a Turnaround
Waters (WAT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
BD Merges Biosciences & Diagnostics Business With Waters
BDX completes its Biosciences & Diagnostic spin-off and Waters merger, securing $4B in proceeds as it pivots to a pure-play MedTech focus.
Waters (WAT) Beats Q4 Earnings and Revenue Estimates
Waters (WAT) came out with quarterly earnings of $4.53 per share, beating the Zacks Consensus Estimate of $4.5 per share. This compares to earnings of $4.1 per share a year ago.
Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth
Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Waters Corporation: Bigger, Better, But Fairly Priced
Waters Corporation: Bigger, Better, But Fairly Priced
Waters Corporation (WAT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Waters Corporation (WAT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Are Functional Waters and Energy Drinks Reviving PepsiCo's PBNA Unit?
PEP's PBNA segment posts organic growth, driven by Pepsi Zero Sugar, Mountain Dew momentum and expanding protein-focused offerings.
Waters (WAT) is a Top-Ranked Growth Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Is Waters (WAT) Up 6.9% Since Last Earnings Report?
Waters (WAT) reported earnings 30 days ago. What's next for the stock?
Waters Corporation (WAT) Presents at Jefferies London Healthcare Conference 2025 Transcript
Waters Corporation ( WAT ) Jefferies London Healthcare Conference 2025 November 18, 2025 9:30 AM EST Company Participants Udit Batra - President, CEO & Director Conference Call Participants Tycho Peterson - Jefferies LLC, Research Division Presentation Tycho Peterson Jefferies LLC, Research Division Okay. Thank you, everybody.
